223 related articles for article (PubMed ID: 18453560)
1. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
[TBL] [Abstract][Full Text] [Related]
2. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
3. Non-glycosidic compounds can stimulate both human and mouse iNKT cells.
Jukes JP; Gileadi U; Ghadbane H; Yu TF; Shepherd D; Cox LR; Besra GS; Cerundolo V
Eur J Immunol; 2016 May; 46(5):1224-34. PubMed ID: 26873393
[TBL] [Abstract][Full Text] [Related]
4. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
[TBL] [Abstract][Full Text] [Related]
6. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
[TBL] [Abstract][Full Text] [Related]
8. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
McCarthy C; Shepherd D; Fleire S; Stronge VS; Koch M; Illarionov PA; Bossi G; Salio M; Denkberg G; Reddington F; Tarlton A; Reddy BG; Schmidt RR; Reiter Y; Griffiths GM; van der Merwe PA; Besra GS; Jones EY; Batista FD; Cerundolo V
J Exp Med; 2007 May; 204(5):1131-44. PubMed ID: 17485514
[TBL] [Abstract][Full Text] [Related]
9. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.
Fox LM; Miksanek J; May NA; Scharf L; Lockridge JL; Veerapen N; Besra GS; Adams EJ; Hudson AW; Gumperz JE
Cancer Immun; 2013; 13():9. PubMed ID: 23885215
[TBL] [Abstract][Full Text] [Related]
11. Application of natural killer T cells in antitumor immunotherapy.
Hong C; Park SH
Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
[TBL] [Abstract][Full Text] [Related]
12. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.
Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F
J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008
[TBL] [Abstract][Full Text] [Related]
13. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
Matulis G; Sanderson JP; Lissin NM; Asparuhova MB; Bommineni GR; Schümperli D; Schmidt RR; Villiger PM; Jakobsen BK; Gadola SD
PLoS Biol; 2010 Jun; 8(6):e1000402. PubMed ID: 20585371
[TBL] [Abstract][Full Text] [Related]
14. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].
Stanic AK; Shashidharamurthy R; Bezbradica JS; Matsuki N; Yoshimura Y; Miyake S; Choi EY; Schell TD; Van Kaer L; Tevethia SS; Roopenian DC; Yamamura T; Joyce S
J Immunol; 2003 Nov; 171(9):4539-51. PubMed ID: 14568927
[TBL] [Abstract][Full Text] [Related]
15. Human invariant NKT cells are required for effective in vitro alloresponses.
Patterson S; Kotsianidis I; Almeida A; Politou M; Rahemtulla A; Matthew B; Schmidt RR; Cerundolo V; Roberts IA; Karadimitris A
J Immunol; 2005 Oct; 175(8):5087-94. PubMed ID: 16210612
[TBL] [Abstract][Full Text] [Related]
16. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
[TBL] [Abstract][Full Text] [Related]
17. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
18. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
[TBL] [Abstract][Full Text] [Related]
19. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
[TBL] [Abstract][Full Text] [Related]
20. Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.
Halder RC; Tran C; Prasad P; Wang J; Nallapothula D; Ishikawa T; Wang M; Zajonc DM; Singh RR
Eur J Immunol; 2019 Feb; 49(2):242-254. PubMed ID: 30508304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
